Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jan 21, 2014; 20(3): 630-638
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.630
Helicobacter pylori gamma-glutamyl transpeptidase and its pathogenic role
Vittorio Ricci, Maria Giannouli, Marco Romano, Raffaele Zarrilli
Vittorio Ricci, Department of Molecular Medicine, Human Physiology Section, University of Pavia Medical School, 27100 Pavia, Italy
Maria Giannouli, Department of Public Health, Hygiene Section, University of Naples “Federico II”, 80131 Naples, Italy
Marco Romano, Department of Clinical and Experimental Medicine, Chair of Gastroenterology, Second University of Naples, 80131 Naples, Italy
Raffaele Zarrilli, Department of Public Health, Hygiene Section, University of Naples “Federico II”, 80131 Naples, Italy
Raffaele Zarrilli, CEINGE Biotecnologie Avanzate, 80131 Naples, Italy
Author contributions: All authors contributed to this manuscrip.
Supported by Italian Ministry for University and Research (Progetto di Ricerca di Interesse Nazionale No. 2009A37C8C_002, to Ricci V); Fondazione Cariplo Grant (No. 2011-0485 to Ricci V); Second University of Naples (CIRANAD to Romano M); and University of Naples “Federico II” (Fondo d’Ateneo per la Ricerca; to Zarrilli R)
Correspondence to: Raffaele Zarrilli, MD, PhD, Department of Public Health, Hygiene Section, University of Naples “Federico II”, 80131 Naples, Italy. rafzarri@unina.it
Telephone: +39-81-7463026 Fax: +39-81-7463352
Received: October 2, 2013
Revised: October 30, 2013
Accepted: November 28, 2013
Published online: January 21, 2014

Abstract

Helicobacter pylori (H. pylori) gamma-glutamyl transpeptidase (GGT) is a bacterial virulence factor that converts glutamine into glutamate and ammonia, and converts glutathione into glutamate and cysteinylglycine. H. pylori GGT causes glutamine and glutathione consumption in the host cells, ammonia production and reactive oxygen species generation. These products induce cell-cycle arrest, apoptosis, and necrosis in gastric epithelial cells. H. pylori GGT may also inhibit apoptosis and induce gastric epithelial cell proliferation through the induction of cyclooxygenase-2, epidermal growth factor-related peptides, inducible nitric oxide synthase and interleukin-8. H. pylori GGT induces immune tolerance through the inhibition of T cell-mediated immunity and dendritic cell differentiation. The effect of GGT on H. pylori colonization and gastric persistence are also discussed.

Key Words: Helicobacter pylori, Gamma-glutamyl transpeptidase, Bacterial virulence factor, Gastric epithelial cell damage, T cell-mediated immunity

Core tip: In this review, we focus on the biochemical features and physiological role of Helicobacter pylori (H. pylori) gamma-glutamyl transpeptidase and analyze the mechanisms through which gamma-glutamyl transpeptidase affects H. pylori gastric colonization, persistence, immune tolerance and damage to the gastric mucosa.



INTRODUCTION

Helicobacter pylori (H. pylori) is a gram-negative, microaerophilic, S-shaped bacterium that colonizes approximately 50% of the world’s population. H. pylori infection causes chronic gastritis, which is asymptomatic in the majority of carriers but may evolve into more severe disease, such as atrophic gastritis, gastric and duodenal ulcers and mucosa-associated lymphoid tissue lymphoma and gastric adenocarcinoma[1]. H. pylori-induced gastroduodenal disease depends on the inflammatory response of the host and on the production of specific virulence factors, such as urease, which is responsible for ammonia generation; the vacuolating cytotoxin VacA; the cytotoxin-associated gene A product CagA; and the type IV secretion system encoded by the cag pathogenicity island[1-4]. Another virulence factor, gamma-glutamyl transpeptidase (GGT), has been shown to play a role in the colonization of the gastric mucosa by H. pylori[5,6], to induce the apoptosis of gastric epithelial cells[7,8], and to inhibit T cell proliferation and dendritic cell differentiation[9-12] (Table 1).

Table 1 Reported Helicobacter pylori gamma-glutamyl transpeptidase effects.
EffectsRef.
Involved in H. pylori colonization and persistence in the gastric mucosa[5,6]
Hydrolysis of extracellular glutamine and glutathione to generate glutamate that is transported into the H. pylori cell[8]
Highly active periplasmic deamidase involved in ammonia production[8,20]
Significantly higher GGT activity in strains obtained from patients with peptic ulcer disease[21]
Gastric epithelial cell death - Mitochondria-mediated apoptosis in gastric epithelial cells[7,16,24]
Cell-cycle arrest of gastric epithelial cells[24]
Glutathione degradation-dependent gastric epithelial cell death[8,27]
H2O2 generation, nuclear factor-κB activation and interleukin-8 production in gastric epithelial cells[21,27]
Induction of EGF-related growth factors and COX-2 in gastric epithelial cells[15]
Induction of apoptosis and inflammation in human biliary cells[25]
Degradation of the apoptosis-inhibiting protein survivin in gastric epithelial cells[30]
Inhibition of T cell proliferation and induction of G1 cell cycle arrest[9-11]
Induction of microRNA-155 in human T cells[38]
Gastric persistence and immune tolerance[12]

In this review, we focus on the biochemical features and physiological role of H. pylori GGT and analyze the mechanisms through which GGT plays a role in H. pylori infection, gastric persistence, immune tolerance and gastric mucosa damage.

BIOCHEMICAL FEATURES AND PHYSIOLOGICAL ROLE OF H. PYLORI GGT

GGT is a threonine N-terminal nucleophile (Ntn) hydrolase that catalyzes the transpeptidation and hydrolysis of the gamma-glutamyl group of glutathione and related compounds[13]. GGT is widely distributed in living organisms and is highly conserved, with mammalian and bacterial homologs often sharing more than 25% of their sequence identity[14]. GGT is found in all gastric Helicobacter species, but among the enterohepatic Helicobacter species, it is found only in H. aurati, H. bilis, H. canis, H. muridarum and H. trogontum[5,7,15,16]. The biochemical features of H. pylori GGT and its physiological role are summarized in Figure 1.

Figure 1
Figure 1 Biochemical features and physiological role of Helicobacter pylori gamma-glutamyl transpeptidase. Helicobacter pylori (H. pylori) gamma-glutamyl transpeptidase (GGT) is a secreted protein of 40 and 20 kDs subunits that converts glutamine to glutamate and ammonia, and glutathione to glutamate and cysteinylglycine. The glutamate produced is then transported into H. pylori cells, where it is incorporated into the tricarboxylic acid (TCA) cycle or utilized for glutamine synthesis.

H. pylori GGT is synthesized as a 60 kDa proenzyme that autocatalytically forms a heterodimer of 40 and 20 kDa subunits[5,7,14,15]. Threonine380 at the N-terminus of the small subunit is the cleavage site, and it is required for the protein’s autocatalytic activity[14]. The enzymatic activity of the protein resides in the small subunit with the gamma-glutamyl binding site at the Tyr433 residue, and the Arg475 residue and the C-terminus of 20 kDa subunit contribute to catalysis[17,18]. H. pylori GGT possesses a signal peptide and has been isolated by two independent research groups as a secreted protein in bacterial broth culture filtrates[15,19]. Nevertheless, another research group identified H. pylori GGT as a periplasmic protein that is likely to associate with the membrane by ionic bonds[7].

Purified H. pylori GGT exhibits hydrolysis activity with very high affinities for glutamine and glutathione. H. pylori GGT converts glutamine into glutamate and ammonia, and converts glutathione into glutamate and cysteinylglycine, through hydrolysis[8]. Because H. pylori cells are unable to directly take up extracellular glutamine and glutathione, these substances are hydrolyzed into glutamate through the action of GGT, either as a secreted or periplasmic enzyme. These results indicate that the main physiological role of H. pylori GGT is to enable bacterial cells to use extracellular glutamine and glutathione as sources of glutamate. The resulting glutamate is then transported by a Na+-dependent reaction into H. pylori cells, where it is primarily incorporated into the TCA cycle and partially used as a substrate for glutamine synthesis[8]. H. pylori GGT also has a physiological roles as a periplasmic deamidase and as a contributor with asparaginase to the extracellular production of ammonia[8,20]. The ammonia produced by H. pylori GGT can be used as a nitrogen source for bacterial cells and for resisting the acidic gastric environment. The extracellular production of ammonia, along with the consumption of extracellular glutathione and glutamine, may alter the redox balance of host cells in the gastric mucosa and render the host cells more sensitive to the toxic effects of reactive oxidizing substances, which in turn cause DNA damage and apoptosis (see below). The physiological roles exerted by H. pylori GGT in bacterial cells and in the host cells could provide metabolic advantages during the establishment of H. pylori infection. In fact, previous studies have shown that H. pylori GGT plays an important role in the bacterial colonization of the gastric mucosa, and H. pylori GGT-defective isogenic strains are unable to colonize[5] or are less efficient[6] at colonizing the gastric mucosa of mice or piglets.

EFFECTS OF H. PYLORI GGT ON GASTRIC EPITHELIAL CELLS

Virulence can be defined as the ability of a pathogen to damage its host[3]. Although virtually all wild-type H. pylori strains produce GGT, strain-to-strain variations in GGT level have been demonstrated among clinical isolates from patients with different disease statuses[21]. In particular, a significantly higher GGT activity has been observed in H. pylori isolates obtained from patients with peptic ulcer disease relative to those obtained from patients with nonulcer dyspepsia[21]. Thus, there is evidence of a direct relationship between GGT production and the development of more severe gastroduodenal diseases. This finding stresses the clinical relevance of GGT as a virulence factor in the overall H. pylori-induced pathogenic action. That gastric ulcer is associated with a high risk of gastric cancer[1] suggests that GGT may play an important role in H. pylori-induced carcinogenesis.

By favoring H. pylori colonization of the gastric mucosa[5,6], likely through its lymphocyte-inhibiting action[10] (see below), GGT might also act indirectly by allowing other independent virulence factors (such as CagA, VacA, etc.) to better exert their damaging actions against the gastric mucosa. Nevertheless, mounting evidence suggests that GGT exerts a direct damaging effect on gastric epithelial cells. The effects of H. pylori GGT on gastric epithelial cells are summarized in Figure 2.

Figure 2
Figure 2 Effects of Helicobacter pylori gamma-glutamyl transpeptidase on gastric epithelial cells. Helicobacter pylori (H. pylori) gamma-glutamyl transpeptidase (GGT) causes consumption of mucosal glutamine and glutathione, production of ammonia and generation of ROS. These products induce caspase activation and apoptosis, ATP-depletion and necrosis, and cell-cycle arrest at G1-S phase in gastric epithelial cells. The effect of vacuolating cytotoxin (VacA) on caspase activation and apoptosis of gastric epithelial cells is also shown. H. pylori GGT may also inhibit apoptosis and induce proliferation through p38 MAPKs, AKT and NF-κB activation and subsequent COX-2, iNOS, growth factors and interleukin-8 (IL-8) induction. ROS: Reactive oxygen species; p38 MAPK: p38 mitogen-activated protein kinase; PI3K: Phosphatidylinositide 3-kinase; AKT: AKT kinase; NF-κB: Nuclear factor κB; COX-2: Cyclo-oxygenase 2; iNOS: Inducible nitric oxide synthase; PG: Prostaglandin.
Apoptosis-related effects

In 2003, Shibayama et al[7] demonstrated that purified H. pylori GGT was able to cause apoptosis in cultured gastric epithelial cells (AGS cell line) in a dose-dependent manner. This proapoptotic activity was strictly dependent on H. pylori GGT enzymatic activity, which was completely blocked by incubation with a glutamine analog that binds and inhibits GGT and other glutaminases. It is well-known that H. pylori infection induces apoptosis in gastric epithelial cells[22]. An increase in apoptosis may play a significant role in the development of pathological outcomes by disturbing the balance between the rate of new cell production and the rate of cell loss, with atrophic gastritis and gastric dysplasia (i.e., gastric preneoplastic lesions) being associated with an increased rate of apoptosis[22]. Interestingly, Shibayama et al[7] also observed that GGT induced necrosis rather than apoptosis in a different gastric epithelial cell line (i.e., KATO III). A similar difference in the type of cell death induced among different experimental models has recently been observed for another H. pylori virulence factor, VacA[23]. This finding raises the key question of how and to what extent the in vitro-derived findings really mimic the in vivo situation[2]. Unlike apoptosis, necrosis results in the release of proinflammatory proteins, thereby augmenting gastric mucosal inflammation and contributing to the pathogenesis of peptic ulceration and gastric cancer[3,23].

In vitro, GGT-induced apoptosis has been shown to occur via the so-called “intrinsic” (i.e., mitochondria-dependent) pathway with the release of cytochrome c in the cytosol and the activation of caspase-9 and -3. These caspases are critical components of the apoptotic machinery and are associated with the up-regulation of proapoptotic members of the Bcl-2 protein family (such as Bax) and the downregulation of antiapoptotic proteins of the same family (Bcl-2 and Bcl-xL)[24]. It is worth noting that similar results have been found recently using human cholangiocarcinoma cells (KKU-100 cell line) as an in vitro cell model, in which H. pylori GGT was also found to increase both the level of iNOS gene expression and the secretion of interleukin (IL)-8[25]. Based on these results, Boonyanugomol et al[25] suggested that H. pylori GGT might be involved in the development of hepatobiliary tract cancer by altering cell kinetics and promoting biliary cell inflammation. However, this intriguing hypothesis remains highly speculative given that, as stressed above, the in vivo biological plausibility and clinical counterpart of the in vitro findings are still far from being confidently ascertained.

Apoptosis-independent antiproliferative effects

Another research group found that recombinant H. pylori GGT showed an apoptosis-independent inhibitory effect on AGS cell proliferation in a dose-dependent manner, although the minimum required protein concentration was 25 times higher than the concentration needed to inhibit the proliferation of human T cells[16]. The discrepancies between these results and those of Shibayama et al[7] have tentatively been attributed to the different methodologies. In particular, only stress conditions such as serum starvation seem to sensitize AGS cells to GGT-dependent apoptosis[16]. Kim et al[26] investigated the effect of H. pylori GGT on cell cycle regulation of AGS cells in serum-containing medium. Although the changes were less marked than those in serum-deprived cells, the investigators confirmed the previously observed apoptotic action of GGT and found, in addition, that GGT caused cell cycle arrest at the G1-S phase transition[26]. Cell cycle arrest was associated with altered expression of specific cell cycle regulatory proteins, namely the down-regulation of cyclin E, cyclin A, cyclin-dependent kinase (Cdk) 4 and Cdk 6, and the up-regulation of the Cdk inhibitors p27 and p21. Thus H. pylori GGT seems to act as a brake at the G1 to S phase transition, thereby disrupting the normal function of several components of the cell cycle which also lead to apoptosis[26].

GGT-activated molecular pathways in gastric epithelial cells

The mechanisms by which the enzymatic activity of H. pylori GGT leads to gastric epithelial cell damage have been carefully investigated by several groups[8,15,20,27]. In mammalian cells, glutathione is synthesized in the cytosol where it reaches mM levels and functions as a redox buffer to detoxify oxidizing molecules. Glutathione may be translocated out of cells, where it serves as a substrate for mammalian cell GGT that is integrated into the plasma membrane using its active site. Because of GGT, the gamma-glutamyl moiety of glutathione is transferred to other amino acids along with the formation of gamma-glutamyl amino acids to be subsequently taken up by the cell; this sequence of events is the so-called “gamma-glutamyl cycle”. Because the Km for the hydrolysis reaction catalyzed by H. pylori GGT is much lower than that of the reaction catalysed by human GGT, gastric epithelium colonization by H. pylori would result in the exhaustive hydrolysis of epithelial cell glutathione[8]. If either the glutathione supply or its synthesis fails to compensate for its H. pylori GGT-dependent hydrolysis, the redox balance of the gastric cell will be impaired. The reduced cytosolic concentration of glutathione makes the epithelial cells more sensitive to the toxic effects of oxidizing molecules, making them more prone to DNA damage, cell cycle alterations, apoptosis and carcinogenesis. Moreover, because glutathione synthesis is an ATP-dependent process, its enhanced degradation by H. pylori GGT would also cause increased compensatory energy consumption by the epithelial cells, which in turn would result in impaired cell viability and proliferation. The hydrolytic activity of H. pylori GGT also exhibits a very high affinity for glutamine, an important nutrient for the gastric mucosa. Extracellular glutamine depletion by bacterial GGT at the H. pylori colonization site would result in the impairment of both the cytoprotective properties of gastric epithelial cells and the immune function of recruited inflammatory cells, for which glutamine is an important respiratory fuel source[8]. In addition, GGT-dependent glutamine hydrolysis is associated with the production of ammonia[8,20], which is well-known not only for its high toxicity to human cells[28] but also for greatly increasing the cytotoxic action of another pivotal H. pylori virulence factor, namely the VacA toxin[29].

Flahou et al[27] recently confirmed that incubating AGS with H. pylori GGT resulted in cell apoptosis. However, they also observed that the supplementation of GGT-treated cells with glutathione strongly enhanced the degree of cell death and resulted in the induction of oncosis/necrosis and not apoptosis. This effect was preceded by increased extracellular H2O2 concentrations, which caused lipid peroxidation. These authors concluded that the GGT-mediated degradation of glutathione results in the generation of pro-oxidant products, in turn leading to epithelial cell death, which will be caused by apoptosis or necrosis depending on the amount of extracellular glutathione available as GGT substrate[27]. Indeed, the type of in vitro H2O2-induced cell death is known to depend on the concentration of this reactive oxygen species (ROS), with the higher concentrations inducing necrosis rather than apoptosis[27]. Like mammalian GGTs, H. pylori GGT-mediated extracellular glutathione catabolism produces ROS (such as H2O2) by thiol-dependent iron reduction, and this production is increased with the addition of exogenous Fe3+ and, conversely, inhibited by treatment with the iron chelator desferrioxamine[21]. Interestingly, it was recently observed[30] that this type of GGT-dependent pathway seems to play a key role in the H. pylori-induced loss of the apoptosis-inhibiting protein survivin in gastric epithelial cells by triggering enhanced proteasomal degradation of the protein. The loss of survivin may thus contribute to the increased cell death induced by H. pylori GGT.

As demonstrated both in AGS gastric cancer cells and in primary non-transformed gastric epithelial cells, the increased production of H2O2 by H. pylori GGT also leads to the activation of nuclear factor-κB and the up-regulation of IL-8 which is known to play a major role in the inflammation-associated mucosal injury induced by H. pylori[21]. Gong and coworkers[21] also found that H. pylori GGT caused oxidative DNA damage, which can be counteracted by preincubation with the H2O2 inhibitor N-acetylcysteine, suggesting a key role for H2O2 generation in GGT-dependent DNA damage. However, Toller et al[31] found that GGT was apparently not involved in DNA double-strand breaks caused by H. pylori in primary and transformed murine and human epithelial/mesenchymal cells, suggesting that H. pylori GGT did not contribute to the genetic instability and chromosomal aberrations observed during gastric carcinogenesis.

Upregulation of EGF-related peptides and COX-2

The molecular cross-talk between H. pylori and human gastric mucosa leading to gastric inflammation and cancer involves also the increased expression of epidermal growth factor (EGF)-related peptides and the activation of the EGF receptor signal transduction pathway as well as upregulation of the expression of cyclooxygenase (COX)-2, the inducible isoform of the enzyme responsible for prostaglandin production[1,2,15]. Our group[15] demonstrated that GGT is the virulence factor responsible for the in vitro up-regulation of both EGF-related peptides and COX-2 in human gastric epithelial cells. This finding was supported by observations showing that all such effects were counteracted by the selective GGT inhibitor acivicin and that an H. pylori isogenic mutant strain defective in GGT did not exert any effect on either EGF-related peptides or COX-2 expression[15]. Apparently, a common signal transduction pathway that relies on the activation of phosphatidylinositol-3 kinase and p38 kinase, but not MAP kinase kinase, triggers the GGT-dependent effects on the cell expression of both EGF-related peptides and COX-2. Notably, the GGT-induced up-regulation of EGF-related peptides and COX-2 mRNA expression was significantly inhibited by treatment with desferrioxamine, which inhibits the formation of ROS generated by cysteinylglycine in the presence of transition metals[15]. This last finding suggests that H. pylori GGT may trigger a proinflammatory and procarcinogenic mucosal response via oxidative stress in gastric mucosal cells.

EFFECTS OF H. PYLORI GGT ON T CELL-MEDIATED IMMUNITY

Mounting evidence indicates that H. pylori GGT may modulate T cell-mediated immunity and contribute to immune evasion during H. pylori infection. Gerhard et al[9] first demonstrated that the inhibition of T cell proliferation by H. pylori is mediated by a low-molecular weight protein secreted by the bacterium. The same research group identified H. pylori GGT as the secreted bacterial protein that induces cell cycle arrest in the G1 phase of T cells and suppresses T cell proliferation[10]. They also identified the disruption of Ras- but not PI3K-dependent signaling by H. pylori GGT as the cause of the G1 arrest, and it also suppressed T cell proliferation[10].

VacA toxin has also been identified as an additional bacterial virulence factor that can efficiently block T cell proliferation by inducing G1/S cell cycle arrest[32,33] and inhibiting the activation of nuclear factor of activated T cells (NFAT), a transcription factor acting as a global regulator of immune response genes[32,34]. Interestingly, impairment of the mitochondrial function has been suggested as an additional mechanism involved in the VacA-induced blockade of CD4+ T cell proliferation[35]. A similar action in the T cell mitochondria might also be hypothesized for GGT, accounting for its proven capacity to damage epithelial cell mitochondria. VacA and GGT released from the bacteria in the gastric mucosa may directly contact intraepithelial T cells or penetrate the mucosa-associated lymphoid tissue (MALT) through the opening of tight junctions brought about by H. pylori[36]. Notably, H. pylori has also been demonstrated to be able to penetrate the gastric epithelium in vivo reaching the underlying lamina propria where it directly contacts immune-inflammatory cells[37].

Because H. pylori is a cholesterol auxotroph and needs to extract this nutrient from host cells, the inhibitory effects of VacA and GGT on the proliferation of human CD4+ T cells is also modulated by the ability of H. pylori to form cholesterol alpha-glucosides[11]. In further support of the roles of VacA and GGT on the inhibition of T cells, it has recently been demonstrated that VacA and H. pylori GGT positively regulate the expression of the non-protein-coding microRNA (miRNA) miR-155 and the master T cell regulator Foxp3 in human lymphocytes through a cAMP-dependent pathway[38].

Both VacA and GGT from H. pylori may also affect T cell activity in an indirect manner by reprogramming dendritic cells to promote the differentiation of naive T cells into T regulatory (Treg) cells[12]. Treg cell differentiation in response to H. pylori infection requires the direct interaction of naive T cells with “tolerogenic” dendritic cells that have been exposed to H. pylori, either in the gastric mucosa or in gastric or mesenteric lymph nodes[39,40]. Dendritic cells that have been exposed to H. pylori fail to induce TH1 and TH17 type T cell responses in vitro and in vivo; instead, such dendritic cells preferentially induce the expression of the Treg cell-specific transcription factor FOXP3, the surface marker CD25 and the anti-inflammatory cytokine IL-10 in naive T cells[12]. This action may contribute to gastric persistence and immune tolerance during infection, and it may independently potentiate the evasion of the immune response generated by the apoptosis of human monocytes in the presence of H. pylori expressing functional cag pathogenicity island[41]. The immune response evasion might also be due to the induction of COX-2 in gastric epithelial cells by H. pylori GGT[15], which has been shown to suppress the TH1 polarization of T cell response to H. pylori[42].

The effects of H. pylori GGT on T cell-mediated immunity could represent the biological basis of observations in animal models, showing an important role for GGT in H. pylori colonization[5,6]. Because H. pylori has been classified as a type I carcinogen[1], the inhibition of immune responses caused by H. pylori GGT might also be an important factor in the induction of malignant MALT lymphoma and adenocarcinoma of the stomach. The effects of H. pylori GGT on T cell-mediated immunity are summarized in Figure 3.

Figure 3
Figure 3 Effects of Helicobacter pylori gamma-glutamyl transpeptidase on T cell-mediated immunity. Helicobacter pylori gamma-glutamyl transpeptidase (GGT) and VacA inhibit T cell proliferation and differentiation to T helper 1 (TH1) and TH17. They also prevent T cell immunity by reprogramming dendritic cells to produce interleukin-10 (IL-10) and IL-18 and promote the differentiation of naive T cells into T regulatory (Treg) cells that further suppress TH1 and TH17 effector functions. FOXP3: Forkhead box P3; NFAT: Nuclear factor of activated T cells; IFN-γ: Interferon gamma.
CONCLUSION

H. pylori produces a combination of virulence factors that damage the gastric mucosa and subvert the host immune response to allow persistent colonization of the challenging environment of the human stomach. In this review, we focussed on H. pylori GGT, a bacterial protein that inhibits cell proliferation and induces the apoptosis of gastric epithelial cells through different pathways involving ammonia and ROS production. This action may contribute to gastric injury during H. pylori infection. Interestingly, H. pylori GGT may also stimulate the expression of antiapoptotic factors and factors that protect against cell damage, such as COX-2 and prostaglandins, EGF-related growth factors and iNOS, which could heal gastric mucosa but may also play a procarcinogenic role during infection. The effects exerted by H. pylori GGT may depend on the level of GGT expression and/or on the concomitant expression of other bacterial virulence factors. Instead, the effect of H. pylori GGT on the inhibition of T cell immunity and dendritic cell maturation may favor colonization and bacterial persistence in the gastric mucosa. The evasion of the immune response by H. pylori GGT may also play a role during gastric carcinogenesis. Increased knowledge of the molecular mechanisms underlying H. pylori infection may lead to the recognition of potential intervention targets to prevent the progression of chronic gastritis to atrophic gastritis and gastric cancer.

Footnotes

P- Reviewers: RajendranVM, Usta J S- Editor: Qi Y L- Editor: A E- Editor: Ma S

References
1.  Romano M, Ricci V, Zarrilli R. Mechanisms of disease: Helicobacter pylori-related gastric carcinogenesis--implications for chemoprevention. Nat Clin Pract Gastroenterol Hepatol. 2006;3:622-632.  [PubMed]  [DOI]
2.  Ricci V, Romano M, Boquet P. Molecular cross-talk between Helicobacter pylori and human gastric mucosa. World J Gastroenterol. 2011;17:1383-1399.  [PubMed]  [DOI]
3.  Boquet P, Ricci V. Intoxication strategy of Helicobacter pylori VacA toxin. Trends Microbiol. 2012;20:165-174.  [PubMed]  [DOI]
4.  Salama NR, Hartung ML, Müller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol. 2013;11:385-399.  [PubMed]  [DOI]
5.  Chevalier C, Thiberge JM, Ferrero RL, Labigne A. Essential role of Helicobacter pylori gamma-glutamyltranspeptidase for the colonization of the gastric mucosa of mice. Mol Microbiol. 1999;31:1359-1372.  [PubMed]  [DOI]
6.  McGovern KJ, Blanchard TG, Gutierrez JA, Czinn SJ, Krakowka S, Youngman P. gamma-Glutamyltransferase is a Helicobacter pylori virulence factor but is not essential for colonization. Infect Immun. 2001;69:4168-4173.  [PubMed]  [DOI]
7.  Shibayama K, Kamachi K, Nagata N, Yagi T, Nada T, Doi Y, Shibata N, Yokoyama K, Yamane K, Kato H. A novel apoptosis-inducing protein from Helicobacter pylori. Mol Microbiol. 2003;47:443-451.  [PubMed]  [DOI]
8.  Shibayama K, Wachino J, Arakawa Y, Saidijam M, Rutherford NG, Henderson PJ. Metabolism of glutamine and glutathione via gamma-glutamyltranspeptidase and glutamate transport in Helicobacter pylori: possible significance in the pathophysiology of the organism. Mol Microbiol. 2007;64:396-406.  [PubMed]  [DOI]
9.  Gerhard M, Schmees C, Voland P, Endres N, Sander M, Reindl W, Rad R, Oelsner M, Decker T, Mempel M. A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells. Gastroenterology. 2005;128:1327-1339.  [PubMed]  [DOI]
10.  Schmees C, Prinz C, Treptau T, Rad R, Hengst L, Voland P, Bauer S, Brenner L, Schmid RM, Gerhard M. Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology. 2007;132:1820-1833.  [PubMed]  [DOI]
11.  Beigier-Bompadre M, Moos V, Belogolova E, Allers K, Schneider T, Churin Y, Ignatius R, Meyer TF, Aebischer T. Modulation of the CD4+ T-cell response by Helicobacter pylori depends on known virulence factors and bacterial cholesterol and cholesterol α-glucoside content. J Infect Dis. 2011;204:1339-1348.  [PubMed]  [DOI]
12.  Oertli M, Noben M, Engler DB, Semper RP, Reuter S, Maxeiner J, Gerhard M, Taube C, Müller A. Helicobacter pylori γ-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance. Proc Natl Acad Sci USA. 2013;110:3047-3052.  [PubMed]  [DOI]
13.  Suzuki H, Kumagai H, Tochikura T. gamma-Glutamyltranspeptidase from Escherichia coli K-12: purification and properties. J Bacteriol. 1986;168:1325-1331.  [PubMed]  [DOI]
14.  Boanca G, Sand A, Barycki JJ. Uncoupling the enzymatic and autoprocessing activities of Helicobacter pylori gamma-glutamyltranspeptidase. J Biol Chem. 2006;281:19029-19037.  [PubMed]  [DOI]
15.  Busiello I, Acquaviva R, Di Popolo A, Blanchard TG, Ricci V, Romano M, Zarrilli R. Helicobacter pylori gamma-glutamyltranspeptidase upregulates COX-2 and EGF-related peptide expression in human gastric cells. Cell Microbiol. 2004;6:255-267.  [PubMed]  [DOI]
16.  Rossi M, Bolz C, Revez J, Javed S, El-Najjar N, Anderl F, Hyytiäinen H, Vuorela P, Gerhard M, Hänninen ML. Evidence for conserved function of γ-glutamyltranspeptidase in Helicobacter genus. PLoS One. 2012;7:e30543.  [PubMed]  [DOI]
17.  Morrow AL, Williams K, Sand A, Boanca G, Barycki JJ. Characterization of Helicobacter pylori gamma-glutamyltranspeptidase reveals the molecular basis for substrate specificity and a critical role for the tyrosine 433-containing loop in catalysis. Biochemistry. 2007;46:13407-13414.  [PubMed]  [DOI]
18.  Williams K, Cullati S, Sand A, Biterova EI, Barycki JJ. Crystal structure of acivicin-inhibited gamma-glutamyltranspeptidase reveals critical roles for its C-terminus in autoprocessing and catalysis. Biochemistry. 2009;48:2459-2467.  [PubMed]  [DOI]
19.  Bumann D, Aksu S, Wendland M, Janek K, Zimny-Arndt U, Sabarth N, Meyer TF, Jungblut PR. Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori. Infect Immun. 2002;70:3396-3403.  [PubMed]  [DOI]
20.  Leduc D, Gallaud J, Stingl K, de Reuse H. Coupled amino acid deamidase-transport systems essential for Helicobacter pylori colonization. Infect Immun. 2010;78:2782-2792.  [PubMed]  [DOI]
21.  Gong M, Ling SS, Lui SY, Yeoh KG, Ho B. Helicobacter pylori gamma-glutamyl transpeptidase is a pathogenic factor in the development of peptic ulcer disease. Gastroenterology. 2010;139:564-573.  [PubMed]  [DOI]
22.  Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol. 2001;96:16-26.  [PubMed]  [DOI]
23.  Radin JN, González-Rivera C, Ivie SE, McClain MS, Cover TL. Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells. Infect Immun. 2011;79:2535-2543.  [PubMed]  [DOI]
24.  Kim KM, Lee SG, Park MG, Song JY, Kang HL, Lee WK, Cho MJ, Rhee KH, Youn HS, Baik SC. Gamma-glutamyltranspeptidase of Helicobacter pylori induces mitochondria-mediated apoptosis in AGS cells. Biochem Biophys Res Commun. 2007;355:562-567.  [PubMed]  [DOI]
25.  Boonyanugomol W, Chomvarin C, Song JY, Kim KM, Kim JM, Cho MJ, Lee WK, Kang HL, Rhee KH, Sripa B. Effects of Helicobacter pylori γ-glutamyltranspeptidase on apoptosis and inflammation in human biliary cells. Dig Dis Sci. 2012;57:2615-2624.  [PubMed]  [DOI]
26.  Kim KM, Lee SG, Kim JM, Kim DS, Song JY, Kang HL, Lee WK, Cho MJ, Rhee KH, Youn HS. Helicobacter pylori gamma-glutamyltranspeptidase induces cell cycle arrest at the G1-S phase transition. J Microbiol. 2010;48:372-377.  [PubMed]  [DOI]
27.  Flahou B, Haesebrouck F, Chiers K, Van Deun K, De Smet L, Devreese B, Vandenberghe I, Favoreel H, Smet A, Pasmans F. Gastric epithelial cell death caused by Helicobacter suis and Helicobacter pylori γ-glutamyl transpeptidase is mainly glutathione degradation-dependent. Cell Microbiol. 2011;13:1933-1955.  [PubMed]  [DOI]
28.  Sommi P, Ricci V, Fiocca R, Romano M, Ivey KJ, Cova E, Solcia E, Ventura U. Significance of ammonia in the genesis of gastric epithelial lesions induced by Helicobacter pylori: an in vitro study with different bacterial strains and urea concentrations. Digestion. 1996;57:299-304.  [PubMed]  [DOI]
29.  Chiozzi V, Mazzini G, Oldani A, Sciullo A, Ventura U, Romano M, Boquet P, Ricci V. Relationship between Vac A toxin and ammonia in Helicobacter pylori-induced apoptosis in human gastric epithelial cells. J Physiol Pharmacol. 2009;60:23-30.  [PubMed]  [DOI]
30.  Valenzuela M, Bravo D, Canales J, Sanhueza C, Díaz N, Almarza O, Toledo H, Quest AF. Helicobacter pylori-induced loss of survivin and gastric cell viability is attributable to secreted bacterial gamma-glutamyl transpeptidase activity. J Infect Dis. 2013;208:1131-1141.  [PubMed]  [DOI]
31.  Toller IM, Neelsen KJ, Steger M, Hartung ML, Hottiger MO, Stucki M, Kalali B, Gerhard M, Sartori AA, Lopes M. Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci USA. 2011;108:14944-14949.  [PubMed]  [DOI]
32.  Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science. 2003;301:1099-1102.  [PubMed]  [DOI]
33.  Sundrud MS, Torres VJ, Unutmaz D, Cover TL. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci USA. 2004;101:7727-7732.  [PubMed]  [DOI]
34.  Sewald X, Gebert-Vogl B, Prassl S, Barwig I, Weiss E, Fabbri M, Osicka R, Schiemann M, Busch DH, Semmrich M. Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. Cell Host Microbe. 2008;3:20-29.  [PubMed]  [DOI]
35.  Torres VJ, VanCompernolle SE, Sundrud MS, Unutmaz D, Cover TL. Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J Immunol. 2007;179:5433-5440.  [PubMed]  [DOI]
36.  Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science. 2003;300:1430-1434.  [PubMed]  [DOI]
37.  Lu H, Yamaoka Y, Graham DY. Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol. 2005;21:653-659.  [PubMed]  [DOI]
38.  Fassi Fehri L, Koch M, Belogolova E, Khalil H, Bolz C, Kalali B, Mollenkopf HJ, Beigier-Bompadre M, Karlas A, Schneider T. Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner. PLoS One. 2010;5:e9500.  [PubMed]  [DOI]
39.  Ito T, Kobayashi D, Uchida K, Takemura T, Nagaoka S, Kobayashi I, Yokoyama T, Ishige I, Ishige Y, Ishida N. Helicobacter pylori invades the gastric mucosa and translocates to the gastric lymph nodes. Lab Invest. 2008;88:664-681.  [PubMed]  [DOI]
40.  Necchi V, Manca R, Ricci V, Solcia E. Evidence for transepithelial dendritic cells in human H. pylori active gastritis. Helicobacter. 2009;14:208-222.  [PubMed]  [DOI]
41.  Galgani M, Busiello I, Censini S, Zappacosta S, Racioppi L, Zarrilli R. Helicobacter pylori induces apoptosis of human monocytes but not monocyte-derived dendritic cells: role of the cag pathogenicity island. Infect Immun. 2004;72:4480-4485.  [PubMed]  [DOI]
42.  Meyer F, Ramanujam KS, Gobert AP, James SP, Wilson KT. Cutting edge: cyclooxygenase-2 activation suppresses Th1 polarization in response to Helicobacter pylori. J Immunol. 2003;171:3913-3917.  [PubMed]  [DOI]